Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling.
Barath UdayasuryanRaffae N AhmadTam T D NguyenAriana UmanaLaDeidra Monét RobertsPolina SobolStephen D JonesJennifer M MunsonDaniel Joseph SladeScott S VerbridgePublished in: Science signaling (2022)
The tumor microbiome is increasingly implicated in cancer progression and resistance to chemotherapy. In pancreatic ductal adenocarcinoma (PDAC), high intratumoral loads of Fusobacterium nucleatum correlate with shorter survival in patients. Here, we investigated the potential mechanisms underlying this association. We found that F. nucleatum infection induced both normal pancreatic epithelial cells and PDAC cells to secrete increased amounts of the cytokines GM-CSF, CXCL1, IL-8, and MIP-3α. These cytokines increased proliferation, migration, and invasive cell motility in both infected and noninfected PDAC cells but not in noncancerous pancreatic epithelial cells, suggesting autocrine and paracrine signaling to PDAC cells. This phenomenon occurred in response to Fusobacterium infection regardless of the strain and in the absence of immune and other stromal cells. Blocking GM-CSF signaling markedly limited proliferative gains after infection. Thus, F. nucleatum infection in the pancreas elicits cytokine secretion from both normal and cancerous cells that promotes phenotypes in PDAC cells associated with tumor progression. The findings support the importance of exploring host-microbe interactions in pancreatic cancer to guide future therapeutic interventions.
Keyphrases
- induced apoptosis
- cell cycle arrest
- signaling pathway
- stem cells
- oxidative stress
- cell death
- endoplasmic reticulum stress
- end stage renal disease
- physical activity
- young adults
- risk assessment
- single cell
- pseudomonas aeruginosa
- peritoneal dialysis
- prognostic factors
- poor prognosis
- candida albicans
- high speed
- drug induced
- cerebrospinal fluid
- long non coding rna
- atomic force microscopy
- chemotherapy induced
- lymph node metastasis